AB APOGEN BIOTECHNOLOGIES Trademark

Trademark Overview

On Friday, December 5, 2014, a trademark application was filed for AB APOGEN BIOTECHNOLOGIES with the United States Patent and Trademark Office. The USPTO has given the AB APOGEN BIOTECHNOLOGIES trademark a serial number of 86472430. The federal status of this trademark filing is REGISTERED as of Tuesday, July 24, 2018. This trademark is owned by ApoGen Biotechnologies, Inc.. The AB APOGEN BIOTECHNOLOGIES trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Medical testing for diagnostic or treatment purposes; Medical testing for diagnostic or treatment purposes in the field of cancer

Research and development in the field of cancer diagnostics
ab apogen biotechnologies

General Information

Serial Number86472430
Word MarkAB APOGEN BIOTECHNOLOGIES
Filing DateFriday, December 5, 2014
Status700 - REGISTERED
Status DateTuesday, July 24, 2018
Registration Number5525124
Registration DateTuesday, July 24, 2018
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, May 19, 2015

Trademark Statements

Description of MarkThe mark consists of the intersecting letters "AB" in a stylized font in which a silhouette of a double helix appears vertically within the "B" all to the left of the words "APOGEN BIOTECHNOLOGIES" in a stylized font in which "APOGEN" appears above "BIOTECHNOLOGIES" with both words scaled to take up the equivalent space horizontally.
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesMedical testing for diagnostic or treatment purposes; Medical testing for diagnostic or treatment purposes in the field of cancer
Disclaimer with Predetermined Text"BIOTECHNOLOGIES"
Goods and ServicesResearch and development in the field of cancer diagnostics

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, December 11, 2014
Primary Code042
First Use Anywhere DateWednesday, November 23, 2016
First Use In Commerce DateWednesday, November 23, 2016
International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, December 11, 2014
Primary Code044
First Use Anywhere DateWednesday, November 23, 2016
First Use In Commerce DateWednesday, November 23, 2016

Trademark Owner History

Party NameApoGen Biotechnologies, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98102
Party NameApoGen Biotechnologies, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSeattle, WA 98102
Party NameApoGen Biotechnologies, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSt. Paul, MN 55108

Trademark Events

Event DateEvent Description
Monday, July 24, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, October 16, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, October 16, 2018TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, July 24, 2018REGISTERED-PRINCIPAL REGISTER
Friday, June 22, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, June 21, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, June 15, 2018STATEMENT OF USE PROCESSING COMPLETE
Monday, June 11, 2018USE AMENDMENT FILED
Monday, June 11, 2018TEAS STATEMENT OF USE RECEIVED
Tuesday, November 21, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 20, 2017SOU EXTENSION 5 GRANTED
Thursday, November 16, 2017SOU EXTENSION 5 FILED
Thursday, November 16, 2017TEAS EXTENSION RECEIVED
Wednesday, July 12, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 10, 2017SOU EXTENSION 4 GRANTED
Monday, July 10, 2017SOU EXTENSION 4 FILED
Monday, July 10, 2017TEAS EXTENSION RECEIVED
Monday, July 10, 2017APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, July 10, 2017TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, January 14, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 12, 2017SOU EXTENSION 3 GRANTED
Thursday, January 12, 2017SOU EXTENSION 3 FILED
Thursday, January 12, 2017TEAS EXTENSION RECEIVED
Friday, January 6, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, January 6, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, August 3, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 2, 2016SOU EXTENSION 2 GRANTED
Wednesday, June 29, 2016SOU EXTENSION 2 FILED
Wednesday, June 29, 2016TEAS EXTENSION RECEIVED
Tuesday, February 2, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, January 30, 2016SOU EXTENSION 1 GRANTED
Wednesday, December 9, 2015SOU EXTENSION 1 FILED
Thursday, January 28, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, December 9, 2015TEAS EXTENSION RECEIVED
Tuesday, July 14, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 19, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 19, 2015PUBLISHED FOR OPPOSITION
Wednesday, April 29, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, April 11, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, April 10, 2015ASSIGNED TO LIE
Friday, March 20, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 20, 2015EXAMINER'S AMENDMENT ENTERED
Friday, March 20, 2015NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, March 20, 2015EXAMINERS AMENDMENT E-MAILED
Friday, March 20, 2015EXAMINERS AMENDMENT -WRITTEN
Friday, March 20, 2015ASSIGNED TO EXAMINER
Friday, December 12, 2014NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, December 11, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 9, 2014NEW APPLICATION ENTERED

Related Keywords

biotechnologies apogen field cancer medical purposes treatment testing diagnostic diagnostics research development